Joint Q4 results mixed, co sees FY 2023 revenue above consensus
- Joint press release (NASDAQ:JYNT): Q4 GAAP EPS of $0.04 misses by $0.03.
- Revenue of $27.8M (+25.8% Y/Y) beats by $0.49M.
- Increased system-wide sales by 18%, to $120.1 million.
- Reported system-wide comp sales of 8%.
- FY 2023 revenue is expected to be between $123.0 million and $128.0 million. The consensus FY 2023 revenue estimate is $121.35M.
- FY 2023 franchised clinic openings are expected to be between 100 and 120, compared to 121 in 2022.